- All
- Product Management
- News
- Introduction
- Enterprise outlets
- FAQ
- Enterprise Video
- Enterprise Atlas
News | Chuangyuan Biotechnology won the first prize in the 2023 Tianjin Intellectual Property Innovation and Entrepreneurship Invention and Design Competition.
Recently, the Tianjin Intellectual Property Office announced the list of winners for the 2023 Tianjin Intellectual Property Innovation and Entrepreneurship Invention and Design Competition. The project "Application and Promotion of Probiotics and Postbiotics in Blood Sugar Reduction" submitted by Tianjin Chuangyuan Biotechnology Co., Ltd. won the first prize.
This competition was jointly initiated and organized by eleven departments, including the Tianjin Intellectual Property Office, Binhai High-tech Zone Management Committee, Municipal Education Commission, Municipal Science and Technology Bureau, Municipal Association for Science and Technology, Municipal Industry and Information Technology Bureau, Municipal Human Resources and Social Security Bureau, Municipal Federation of Trade Unions, Municipal Youth League Committee, Municipal Women's Federation, and Municipal Federation of Industry and Commerce. The aim is to fully implement the spirit of the 20th National Congress of the Communist Party, deeply carry out General Secretary Xi Jinping's important discourse on intellectual property protection, thoroughly implement the "Tianjin Intellectual Property Strong City Construction Outline (2021-2035)" and the "Tianjin Intellectual Property 14th Five-Year Plan", and deeply integrate into Tianjin's "Ten Actions", providing strong support for creating a good business environment, promoting innovation-driven development, and building a strong intellectual property city.
After six months of intense competition, and through strict preliminary review by organizing units, expert evaluation, and approval by the director's office, ten first prizes, twenty second prizes, and thirty third prizes were awarded from twelve key industrial chains and technological innovation projects in the city. The Chuangyuan Biotechnology team, relying on its independent innovation research and development strength and persistent scientific research attitude, adhered to scientific inquiry, enhanced its technological core, and received high recognition from judges and leaders, winning the first prize.
As a national high-tech enterprise, Chuangyuan Biotechnology is based on internationally advanced segmented solid-state fermentation technology for various probiotics, insisting on technological innovation as the core driving force, actively integrating into national strategies, responding to the call of "Healthy China" and local governments to promote economic construction, focusing on high-tech innovation, high-quality development, and high-quality services, and continuously deepening research in the fields of micro-ecological preparations and postbiotics. To date, the company has invested over 30 million yuan in research and development, holds 26 invention patents, 24 utility model patents, and has launched more than 30 self-owned brand products; it has served over 200 clients and produced more than 150 ODM/OEM products.

With the full production of the second phase project, Chuangyuan Biotechnology's industrial layout is becoming increasingly complete, and the industrial momentum is further released. The company will continue to take "Creating the Source of Life and Health" as the core engine for high-quality development, constantly surpassing itself, providing strong guarantees for the health of the entire population, and striving to become a first-class international biotechnology enterprise in the big health industry that is respected, trustworthy, innovative, and where employees are happy and customers are satisfied!

Related News